Suchergebnisse - "Maiorano, Brigida Anna"

PubPharm (41)

1

Real World Analysis of Peritoneal Metastasis From Renal Cell Carcinoma. Meet-Uro27

enthalten in: Clinical genitourinary cancer | 2024

von Stellato, M. | Buti, S. | Maruzzo, M. | +19

2

Clinical Outcomes and Prognostic Factors in Patients With Penile Carcinoma : A Sub-Analysis From Meet-URO 23 (I-RARE) Registry Study

enthalten in: Clinical genitourinary cancer | 2024

von Mollica, V. | Massari, F. | Maruzzo, M. | +22

3

Significance of PD-L1 in Metastatic Urothelial Carcinoma Treated With Immune Checkpoint Inhibitors : A Systematic Review and Meta-Analysis

enthalten in: JAMA network open | 2024

von Maiorano, B. | Di Maio, M. | Cerbone, L. | +104

4

Hematological Toxicity of PARP Inhibitors in Metastatic Prostate Cancer Patients with Mutations of BRCA or HRR Genes : A Systematic Review and Safety Meta-analysis

enthalten in: Targeted oncology | 2024

von Maiorano, B. | De Giorgi, U. | Verzoni, E. | +5

ErratumIn: Target Oncol. 2023 Dec 9;:. - PMID 38070004

5

Correction to : Hematological Toxicity of PARP Inhibitors in Metastatic Prostate Cancer Patients with Mutations of BRCA or HRR Genes: A Systematic Review and Safety Meta-analysis

enthalten in: Targeted oncology | 2024

von Maiorano, B. | De Giorgi, U. | Verzoni, E. | +5

ErratumFor: Target Oncol. 2024 Jan;19(1):1-11. - PMID 37993604

6

Immune checkpoint inhibitors plus chemotherapy in first-line endometrial cancer treatment : Still the era of microsatellites?

enthalten in: BJOG : an international journal of obstetrics and gynaecology | 2024

von Maiorano, M. | Messina, C. | Maiello, E. | +2

7

Personalized medicine for metastatic prostate cancer : The paradigm of PARP inhibitors

enthalten in: Critical reviews in oncology/hematology | 2023

von Maiorano, B. | Conteduca, V. | Catalano, M. | +4

8

Niraparib and Advanced Ovarian Cancer : A Beacon in the Non-BRCA Mutated Setting

enthalten in: Pharmaceuticals (Basel, Switzerland) | 2023

von Maiorano, M. | Maiorano, B. | Biancofiore, A. | +2

9

Comparison of Anti-Programmed Cell Death Ligand 1 Therapy Combinations vs Sunitinib for Metastatic Renal Cell Carcinoma : A Meta-analysis

enthalten in: JAMA network open | 2023

von Maiorano, B. | Ciardiello, D. | Maiello, E. | +1

10

Letter : be careful of gastrointestinal CMV infection in adverse events from ICIs therapy in solid tumours

enthalten in: Alimentary pharmacology & therapeutics | 2023

von Parente, P. | Ascani, S. | Maiorano, B. | +2

CommentOn: Aliment Pharmacol Ther. 2022 Nov;56(9):1370-1382. - PMID 36123319

1
2
3
4
5
Nächster »
[5]